nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—MAOA—locus ceruleus—Alzheimer's disease	0.0237	0.141	CbGeAlD
Zolmitriptan—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0153	0.0908	CbGeAlD
Zolmitriptan—HTR1D—telencephalic ventricle—Alzheimer's disease	0.0148	0.0879	CbGeAlD
Zolmitriptan—HTR1A—telencephalic ventricle—Alzheimer's disease	0.0123	0.0733	CbGeAlD
Zolmitriptan—HTR1F—forebrain—Alzheimer's disease	0.00973	0.0579	CbGeAlD
Zolmitriptan—HTR1F—telencephalon—Alzheimer's disease	0.00895	0.0532	CbGeAlD
Zolmitriptan—HTR1B—blood vessel—Alzheimer's disease	0.00756	0.0449	CbGeAlD
Zolmitriptan—HTR1D—blood vessel—Alzheimer's disease	0.00732	0.0435	CbGeAlD
Zolmitriptan—HTR1F—nervous system—Alzheimer's disease	0.00528	0.0314	CbGeAlD
Zolmitriptan—Melatonin—MT3—Alzheimer's disease	0.00527	0.411	CrCbGaD
Zolmitriptan—HTR1F—central nervous system—Alzheimer's disease	0.00509	0.0302	CbGeAlD
Zolmitriptan—HTR1F—brain—Alzheimer's disease	0.00404	0.024	CbGeAlD
Zolmitriptan—HTR1B—forebrain—Alzheimer's disease	0.00399	0.0237	CbGeAlD
Zolmitriptan—HTR1D—forebrain—Alzheimer's disease	0.00386	0.023	CbGeAlD
Zolmitriptan—HTR1B—telencephalon—Alzheimer's disease	0.00367	0.0218	CbGeAlD
Zolmitriptan—HTR1D—telencephalon—Alzheimer's disease	0.00355	0.0211	CbGeAlD
Zolmitriptan—MAOA—embryo—Alzheimer's disease	0.00332	0.0198	CbGeAlD
Zolmitriptan—HTR1A—forebrain—Alzheimer's disease	0.00322	0.0191	CbGeAlD
Zolmitriptan—HTR1A—telencephalon—Alzheimer's disease	0.00296	0.0176	CbGeAlD
Zolmitriptan—MAOA—forebrain—Alzheimer's disease	0.00294	0.0175	CbGeAlD
Zolmitriptan—MAOA—telencephalon—Alzheimer's disease	0.0027	0.0161	CbGeAlD
Zolmitriptan—Melatonin—CALM1—Alzheimer's disease	0.00251	0.196	CrCbGaD
Zolmitriptan—HTR1B—nervous system—Alzheimer's disease	0.00216	0.0129	CbGeAlD
Zolmitriptan—HTR1D—nervous system—Alzheimer's disease	0.0021	0.0125	CbGeAlD
Zolmitriptan—HTR1B—central nervous system—Alzheimer's disease	0.00208	0.0124	CbGeAlD
Zolmitriptan—HTR1D—central nervous system—Alzheimer's disease	0.00202	0.012	CbGeAlD
Zolmitriptan—HTR1A—nervous system—Alzheimer's disease	0.00175	0.0104	CbGeAlD
Zolmitriptan—HTR1A—central nervous system—Alzheimer's disease	0.00168	0.01	CbGeAlD
Zolmitriptan—HTR1B—brain—Alzheimer's disease	0.00165	0.00984	CbGeAlD
Zolmitriptan—HTR1A—cerebellum—Alzheimer's disease	0.00164	0.00978	CbGeAlD
Zolmitriptan—HTR1D—brain—Alzheimer's disease	0.0016	0.00953	CbGeAlD
Zolmitriptan—MAOA—nervous system—Alzheimer's disease	0.0016	0.00949	CbGeAlD
Zolmitriptan—MAOA—central nervous system—Alzheimer's disease	0.00154	0.00914	CbGeAlD
Zolmitriptan—MAOA—cerebellum—Alzheimer's disease	0.0015	0.00893	CbGeAlD
Zolmitriptan—Melatonin—MPO—Alzheimer's disease	0.00137	0.107	CrCbGaD
Zolmitriptan—HTR1A—brain—Alzheimer's disease	0.00134	0.00794	CbGeAlD
Zolmitriptan—MAOA—brain—Alzheimer's disease	0.00122	0.00725	CbGeAlD
Zolmitriptan—Eletriptan—PTGS1—Alzheimer's disease	0.00103	0.0806	CrCbGaD
Zolmitriptan—Melatonin—ESR1—Alzheimer's disease	0.00102	0.08	CrCbGaD
Zolmitriptan—Almotriptan—CYP2D6—Alzheimer's disease	0.000902	0.0704	CrCbGaD
Zolmitriptan—Convulsion—Galantamine—Alzheimer's disease	0.000788	0.00135	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000785	0.00134	CcSEcCtD
Zolmitriptan—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000785	0.00134	CcSEcCtD
Zolmitriptan—Hypertension—Galantamine—Alzheimer's disease	0.000785	0.00134	CcSEcCtD
Zolmitriptan—Haematuria—Memantine—Alzheimer's disease	0.000781	0.00133	CcSEcCtD
Zolmitriptan—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000779	0.00133	CcSEcCtD
Zolmitriptan—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000779	0.00133	CcSEcCtD
Zolmitriptan—Arthralgia—Galantamine—Alzheimer's disease	0.000774	0.00132	CcSEcCtD
Zolmitriptan—Myalgia—Galantamine—Alzheimer's disease	0.000774	0.00132	CcSEcCtD
Zolmitriptan—Chest pain—Galantamine—Alzheimer's disease	0.000774	0.00132	CcSEcCtD
Zolmitriptan—Epistaxis—Memantine—Alzheimer's disease	0.000772	0.00132	CcSEcCtD
Zolmitriptan—Anxiety—Galantamine—Alzheimer's disease	0.000772	0.00132	CcSEcCtD
Zolmitriptan—Sinusitis—Memantine—Alzheimer's disease	0.000768	0.00131	CcSEcCtD
Zolmitriptan—Sweating—Rivastigmine—Alzheimer's disease	0.000768	0.00131	CcSEcCtD
Zolmitriptan—Discomfort—Galantamine—Alzheimer's disease	0.000765	0.00131	CcSEcCtD
Zolmitriptan—Haematuria—Rivastigmine—Alzheimer's disease	0.000764	0.00131	CcSEcCtD
Zolmitriptan—Dry mouth—Galantamine—Alzheimer's disease	0.000757	0.00129	CcSEcCtD
Zolmitriptan—Epistaxis—Rivastigmine—Alzheimer's disease	0.000756	0.00129	CcSEcCtD
Zolmitriptan—Tinnitus—Donepezil—Alzheimer's disease	0.000755	0.00129	CcSEcCtD
Zolmitriptan—Sinusitis—Rivastigmine—Alzheimer's disease	0.000752	0.00129	CcSEcCtD
Zolmitriptan—Confusional state—Galantamine—Alzheimer's disease	0.000748	0.00128	CcSEcCtD
Zolmitriptan—Bradycardia—Memantine—Alzheimer's disease	0.000748	0.00128	CcSEcCtD
Zolmitriptan—Rhinitis—Memantine—Alzheimer's disease	0.000737	0.00126	CcSEcCtD
Zolmitriptan—Bradycardia—Rivastigmine—Alzheimer's disease	0.000732	0.00125	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Memantine—Alzheimer's disease	0.000731	0.00125	CcSEcCtD
Zolmitriptan—Hallucination—Memantine—Alzheimer's disease	0.000731	0.00125	CcSEcCtD
Zolmitriptan—Shock—Galantamine—Alzheimer's disease	0.00073	0.00125	CcSEcCtD
Zolmitriptan—Pharyngitis—Memantine—Alzheimer's disease	0.00073	0.00125	CcSEcCtD
Zolmitriptan—Nervous system disorder—Galantamine—Alzheimer's disease	0.000728	0.00124	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000727	0.00124	CcSEcCtD
Zolmitriptan—Chills—Donepezil—Alzheimer's disease	0.000726	0.00124	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Memantine—Alzheimer's disease	0.000726	0.00124	CcSEcCtD
Zolmitriptan—Tachycardia—Galantamine—Alzheimer's disease	0.000724	0.00124	CcSEcCtD
Zolmitriptan—Oedema peripheral—Memantine—Alzheimer's disease	0.000724	0.00124	CcSEcCtD
Zolmitriptan—Arrhythmia—Donepezil—Alzheimer's disease	0.000723	0.00124	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Memantine—Alzheimer's disease	0.000722	0.00124	CcSEcCtD
Zolmitriptan—Rhinitis—Rivastigmine—Alzheimer's disease	0.000721	0.00123	CcSEcCtD
Zolmitriptan—Skin disorder—Galantamine—Alzheimer's disease	0.000721	0.00123	CcSEcCtD
Zolmitriptan—Urethral disorder—Memantine—Alzheimer's disease	0.000721	0.00123	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000718	0.00123	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000716	0.00122	CcSEcCtD
Zolmitriptan—Hallucination—Rivastigmine—Alzheimer's disease	0.000716	0.00122	CcSEcCtD
Zolmitriptan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000714	0.00122	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00071	0.00121	CcSEcCtD
Zolmitriptan—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000708	0.00121	CcSEcCtD
Zolmitriptan—Anorexia—Galantamine—Alzheimer's disease	0.000707	0.00121	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000707	0.00121	CcSEcCtD
Zolmitriptan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000705	0.00121	CcSEcCtD
Zolmitriptan—Erythema—Donepezil—Alzheimer's disease	0.000705	0.00121	CcSEcCtD
Zolmitriptan—Eletriptan—CYP2D6—Alzheimer's disease	0.000703	0.0549	CrCbGaD
Zolmitriptan—Tension—Donepezil—Alzheimer's disease	0.000692	0.00118	CcSEcCtD
Zolmitriptan—Dysgeusia—Donepezil—Alzheimer's disease	0.00069	0.00118	CcSEcCtD
Zolmitriptan—Tinnitus—Memantine—Alzheimer's disease	0.000685	0.00117	CcSEcCtD
Zolmitriptan—Nervousness—Donepezil—Alzheimer's disease	0.000685	0.00117	CcSEcCtD
Zolmitriptan—Cardiac disorder—Memantine—Alzheimer's disease	0.000682	0.00117	CcSEcCtD
Zolmitriptan—Back pain—Donepezil—Alzheimer's disease	0.000682	0.00117	CcSEcCtD
Zolmitriptan—Muscle spasms—Donepezil—Alzheimer's disease	0.000678	0.00116	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000676	0.00116	CcSEcCtD
Zolmitriptan—Insomnia—Galantamine—Alzheimer's disease	0.000671	0.00115	CcSEcCtD
Zolmitriptan—Tinnitus—Rivastigmine—Alzheimer's disease	0.000671	0.00115	CcSEcCtD
Zolmitriptan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000667	0.00114	CcSEcCtD
Zolmitriptan—Angiopathy—Memantine—Alzheimer's disease	0.000667	0.00114	CcSEcCtD
Zolmitriptan—Paraesthesia—Galantamine—Alzheimer's disease	0.000666	0.00114	CcSEcCtD
Zolmitriptan—Immune system disorder—Memantine—Alzheimer's disease	0.000664	0.00114	CcSEcCtD
Zolmitriptan—Tremor—Donepezil—Alzheimer's disease	0.00066	0.00113	CcSEcCtD
Zolmitriptan—Somnolence—Galantamine—Alzheimer's disease	0.00066	0.00113	CcSEcCtD
Zolmitriptan—Chills—Memantine—Alzheimer's disease	0.00066	0.00113	CcSEcCtD
Zolmitriptan—Arrhythmia—Memantine—Alzheimer's disease	0.000657	0.00112	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000654	0.00112	CcSEcCtD
Zolmitriptan—Dyspepsia—Galantamine—Alzheimer's disease	0.000653	0.00112	CcSEcCtD
Zolmitriptan—Angiopathy—Rivastigmine—Alzheimer's disease	0.000652	0.00112	CcSEcCtD
Zolmitriptan—Agitation—Donepezil—Alzheimer's disease	0.000648	0.00111	CcSEcCtD
Zolmitriptan—Chills—Rivastigmine—Alzheimer's disease	0.000645	0.0011	CcSEcCtD
Zolmitriptan—Decreased appetite—Galantamine—Alzheimer's disease	0.000645	0.0011	CcSEcCtD
Zolmitriptan—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000642	0.0011	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000641	0.0011	CcSEcCtD
Zolmitriptan—Malaise—Donepezil—Alzheimer's disease	0.000636	0.00109	CcSEcCtD
Zolmitriptan—Constipation—Galantamine—Alzheimer's disease	0.000635	0.00109	CcSEcCtD
Zolmitriptan—Vertigo—Donepezil—Alzheimer's disease	0.000633	0.00108	CcSEcCtD
Zolmitriptan—Syncope—Donepezil—Alzheimer's disease	0.000632	0.00108	CcSEcCtD
Zolmitriptan—Tension—Memantine—Alzheimer's disease	0.000628	0.00107	CcSEcCtD
Zolmitriptan—Dysgeusia—Memantine—Alzheimer's disease	0.000627	0.00107	CcSEcCtD
Zolmitriptan—Erythema—Rivastigmine—Alzheimer's disease	0.000626	0.00107	CcSEcCtD
Zolmitriptan—Nervousness—Memantine—Alzheimer's disease	0.000622	0.00106	CcSEcCtD
Zolmitriptan—Loss of consciousness—Donepezil—Alzheimer's disease	0.000619	0.00106	CcSEcCtD
Zolmitriptan—Back pain—Memantine—Alzheimer's disease	0.000619	0.00106	CcSEcCtD
Zolmitriptan—Cough—Donepezil—Alzheimer's disease	0.000615	0.00105	CcSEcCtD
Zolmitriptan—Tension—Rivastigmine—Alzheimer's disease	0.000614	0.00105	CcSEcCtD
Zolmitriptan—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000613	0.00105	CcSEcCtD
Zolmitriptan—Feeling abnormal—Galantamine—Alzheimer's disease	0.000612	0.00105	CcSEcCtD
Zolmitriptan—Convulsion—Donepezil—Alzheimer's disease	0.000611	0.00104	CcSEcCtD
Zolmitriptan—Hypertension—Donepezil—Alzheimer's disease	0.000608	0.00104	CcSEcCtD
Zolmitriptan—Nervousness—Rivastigmine—Alzheimer's disease	0.000608	0.00104	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000607	0.00104	CcSEcCtD
Zolmitriptan—Back pain—Rivastigmine—Alzheimer's disease	0.000606	0.00104	CcSEcCtD
Zolmitriptan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000602	0.00103	CcSEcCtD
Zolmitriptan—Myalgia—Donepezil—Alzheimer's disease	0.0006	0.00103	CcSEcCtD
Zolmitriptan—Arthralgia—Donepezil—Alzheimer's disease	0.0006	0.00103	CcSEcCtD
Zolmitriptan—Chest pain—Donepezil—Alzheimer's disease	0.0006	0.00103	CcSEcCtD
Zolmitriptan—Tremor—Memantine—Alzheimer's disease	0.0006	0.00103	CcSEcCtD
Zolmitriptan—Anxiety—Donepezil—Alzheimer's disease	0.000598	0.00102	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Memantine—Alzheimer's disease	0.000594	0.00102	CcSEcCtD
Zolmitriptan—Discomfort—Donepezil—Alzheimer's disease	0.000593	0.00101	CcSEcCtD
Zolmitriptan—Agitation—Memantine—Alzheimer's disease	0.000588	0.00101	CcSEcCtD
Zolmitriptan—Dry mouth—Donepezil—Alzheimer's disease	0.000587	0.001	CcSEcCtD
Zolmitriptan—Abdominal pain—Galantamine—Alzheimer's disease	0.000587	0.001	CcSEcCtD
Zolmitriptan—Body temperature increased—Galantamine—Alzheimer's disease	0.000587	0.001	CcSEcCtD
Zolmitriptan—Tremor—Rivastigmine—Alzheimer's disease	0.000587	0.001	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000581	0.000993	CcSEcCtD
Zolmitriptan—Confusional state—Donepezil—Alzheimer's disease	0.00058	0.000992	CcSEcCtD
Zolmitriptan—Malaise—Memantine—Alzheimer's disease	0.000577	0.000987	CcSEcCtD
Zolmitriptan—Agitation—Rivastigmine—Alzheimer's disease	0.000575	0.000984	CcSEcCtD
Zolmitriptan—Oedema—Donepezil—Alzheimer's disease	0.000575	0.000983	CcSEcCtD
Zolmitriptan—Vertigo—Memantine—Alzheimer's disease	0.000575	0.000983	CcSEcCtD
Zolmitriptan—Syncope—Memantine—Alzheimer's disease	0.000574	0.000981	CcSEcCtD
Zolmitriptan—Leukopenia—Memantine—Alzheimer's disease	0.000573	0.000979	CcSEcCtD
Zolmitriptan—Infection—Donepezil—Alzheimer's disease	0.000571	0.000977	CcSEcCtD
Zolmitriptan—Shock—Donepezil—Alzheimer's disease	0.000566	0.000968	CcSEcCtD
Zolmitriptan—Palpitations—Memantine—Alzheimer's disease	0.000566	0.000967	CcSEcCtD
Zolmitriptan—Malaise—Rivastigmine—Alzheimer's disease	0.000565	0.000965	CcSEcCtD
Zolmitriptan—Nervous system disorder—Donepezil—Alzheimer's disease	0.000564	0.000964	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000563	0.000963	CcSEcCtD
Zolmitriptan—Vertigo—Rivastigmine—Alzheimer's disease	0.000562	0.000962	CcSEcCtD
Zolmitriptan—Loss of consciousness—Memantine—Alzheimer's disease	0.000562	0.000962	CcSEcCtD
Zolmitriptan—Syncope—Rivastigmine—Alzheimer's disease	0.000561	0.00096	CcSEcCtD
Zolmitriptan—Cough—Memantine—Alzheimer's disease	0.000558	0.000955	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000556	0.000951	CcSEcCtD
Zolmitriptan—Convulsion—Memantine—Alzheimer's disease	0.000554	0.000948	CcSEcCtD
Zolmitriptan—Palpitations—Rivastigmine—Alzheimer's disease	0.000553	0.000946	CcSEcCtD
Zolmitriptan—Hypertension—Memantine—Alzheimer's disease	0.000552	0.000945	CcSEcCtD
Zolmitriptan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00055	0.000941	CcSEcCtD
Zolmitriptan—Anorexia—Donepezil—Alzheimer's disease	0.000548	0.000937	CcSEcCtD
Zolmitriptan—Hypersensitivity—Galantamine—Alzheimer's disease	0.000547	0.000935	CcSEcCtD
Zolmitriptan—Cough—Rivastigmine—Alzheimer's disease	0.000546	0.000934	CcSEcCtD
Zolmitriptan—Chest pain—Memantine—Alzheimer's disease	0.000545	0.000932	CcSEcCtD
Zolmitriptan—Arthralgia—Memantine—Alzheimer's disease	0.000545	0.000932	CcSEcCtD
Zolmitriptan—Myalgia—Memantine—Alzheimer's disease	0.000545	0.000932	CcSEcCtD
Zolmitriptan—Anxiety—Memantine—Alzheimer's disease	0.000543	0.000928	CcSEcCtD
Zolmitriptan—Convulsion—Rivastigmine—Alzheimer's disease	0.000542	0.000927	CcSEcCtD
Zolmitriptan—Hypertension—Rivastigmine—Alzheimer's disease	0.00054	0.000924	CcSEcCtD
Zolmitriptan—Discomfort—Memantine—Alzheimer's disease	0.000538	0.00092	CcSEcCtD
Zolmitriptan—Arthralgia—Rivastigmine—Alzheimer's disease	0.000533	0.000911	CcSEcCtD
Zolmitriptan—Myalgia—Rivastigmine—Alzheimer's disease	0.000533	0.000911	CcSEcCtD
Zolmitriptan—Chest pain—Rivastigmine—Alzheimer's disease	0.000533	0.000911	CcSEcCtD
Zolmitriptan—Dry mouth—Memantine—Alzheimer's disease	0.000533	0.000911	CcSEcCtD
Zolmitriptan—Asthenia—Galantamine—Alzheimer's disease	0.000533	0.000911	CcSEcCtD
Zolmitriptan—Anxiety—Rivastigmine—Alzheimer's disease	0.000531	0.000908	CcSEcCtD
Zolmitriptan—Confusional state—Memantine—Alzheimer's disease	0.000527	0.0009	CcSEcCtD
Zolmitriptan—Discomfort—Rivastigmine—Alzheimer's disease	0.000527	0.0009	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000524	0.000896	CcSEcCtD
Zolmitriptan—Oedema—Memantine—Alzheimer's disease	0.000522	0.000893	CcSEcCtD
Zolmitriptan—Dry mouth—Rivastigmine—Alzheimer's disease	0.000521	0.000891	CcSEcCtD
Zolmitriptan—Insomnia—Donepezil—Alzheimer's disease	0.00052	0.00089	CcSEcCtD
Zolmitriptan—Infection—Memantine—Alzheimer's disease	0.000519	0.000887	CcSEcCtD
Zolmitriptan—Paraesthesia—Donepezil—Alzheimer's disease	0.000517	0.000883	CcSEcCtD
Zolmitriptan—Confusional state—Rivastigmine—Alzheimer's disease	0.000515	0.000881	CcSEcCtD
Zolmitriptan—Shock—Memantine—Alzheimer's disease	0.000514	0.000879	CcSEcCtD
Zolmitriptan—Dyspnoea—Donepezil—Alzheimer's disease	0.000513	0.000877	CcSEcCtD
Zolmitriptan—Nervous system disorder—Memantine—Alzheimer's disease	0.000512	0.000876	CcSEcCtD
Zolmitriptan—Somnolence—Donepezil—Alzheimer's disease	0.000511	0.000874	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Memantine—Alzheimer's disease	0.000511	0.000874	CcSEcCtD
Zolmitriptan—Oedema—Rivastigmine—Alzheimer's disease	0.000511	0.000874	CcSEcCtD
Zolmitriptan—Tachycardia—Memantine—Alzheimer's disease	0.00051	0.000872	CcSEcCtD
Zolmitriptan—Diarrhoea—Galantamine—Alzheimer's disease	0.000508	0.000868	CcSEcCtD
Zolmitriptan—Infection—Rivastigmine—Alzheimer's disease	0.000508	0.000868	CcSEcCtD
Zolmitriptan—Skin disorder—Memantine—Alzheimer's disease	0.000507	0.000867	CcSEcCtD
Zolmitriptan—Dyspepsia—Donepezil—Alzheimer's disease	0.000506	0.000866	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Memantine—Alzheimer's disease	0.000505	0.000863	CcSEcCtD
Zolmitriptan—Shock—Rivastigmine—Alzheimer's disease	0.000503	0.000859	CcSEcCtD
Zolmitriptan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000501	0.000857	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.0005	0.000855	CcSEcCtD
Zolmitriptan—Decreased appetite—Donepezil—Alzheimer's disease	0.0005	0.000855	CcSEcCtD
Zolmitriptan—Tachycardia—Rivastigmine—Alzheimer's disease	0.000499	0.000853	CcSEcCtD
Zolmitriptan—Anorexia—Memantine—Alzheimer's disease	0.000498	0.000851	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000497	0.000849	CcSEcCtD
Zolmitriptan—Skin disorder—Rivastigmine—Alzheimer's disease	0.000496	0.000849	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000494	0.000845	CcSEcCtD
Zolmitriptan—Pain—Donepezil—Alzheimer's disease	0.000492	0.000841	CcSEcCtD
Zolmitriptan—Constipation—Donepezil—Alzheimer's disease	0.000492	0.000841	CcSEcCtD
Zolmitriptan—Dizziness—Galantamine—Alzheimer's disease	0.000491	0.000839	CcSEcCtD
Zolmitriptan—Anorexia—Rivastigmine—Alzheimer's disease	0.000487	0.000833	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000476	0.000814	CcSEcCtD
Zolmitriptan—Feeling abnormal—Donepezil—Alzheimer's disease	0.000474	0.00081	CcSEcCtD
Zolmitriptan—Insomnia—Memantine—Alzheimer's disease	0.000472	0.000808	CcSEcCtD
Zolmitriptan—Vomiting—Galantamine—Alzheimer's disease	0.000472	0.000807	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00047	0.000804	CcSEcCtD
Zolmitriptan—Paraesthesia—Memantine—Alzheimer's disease	0.000469	0.000802	CcSEcCtD
Zolmitriptan—Rash—Galantamine—Alzheimer's disease	0.000468	0.0008	CcSEcCtD
Zolmitriptan—Dermatitis—Galantamine—Alzheimer's disease	0.000468	0.000799	CcSEcCtD
Zolmitriptan—Dyspnoea—Memantine—Alzheimer's disease	0.000466	0.000796	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000465	0.000796	CcSEcCtD
Zolmitriptan—Headache—Galantamine—Alzheimer's disease	0.000465	0.000795	CcSEcCtD
Zolmitriptan—Somnolence—Memantine—Alzheimer's disease	0.000464	0.000794	CcSEcCtD
Zolmitriptan—Insomnia—Rivastigmine—Alzheimer's disease	0.000462	0.00079	CcSEcCtD
Zolmitriptan—Dyspepsia—Memantine—Alzheimer's disease	0.00046	0.000786	CcSEcCtD
Zolmitriptan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000459	0.000784	CcSEcCtD
Zolmitriptan—Urticaria—Donepezil—Alzheimer's disease	0.000457	0.000781	CcSEcCtD
Zolmitriptan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000456	0.000779	CcSEcCtD
Zolmitriptan—Abdominal pain—Donepezil—Alzheimer's disease	0.000455	0.000777	CcSEcCtD
Zolmitriptan—Body temperature increased—Donepezil—Alzheimer's disease	0.000455	0.000777	CcSEcCtD
Zolmitriptan—Somnolence—Rivastigmine—Alzheimer's disease	0.000454	0.000777	CcSEcCtD
Zolmitriptan—Decreased appetite—Memantine—Alzheimer's disease	0.000454	0.000776	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000451	0.000771	CcSEcCtD
Zolmitriptan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00045	0.000769	CcSEcCtD
Zolmitriptan—Constipation—Memantine—Alzheimer's disease	0.000447	0.000764	CcSEcCtD
Zolmitriptan—Pain—Memantine—Alzheimer's disease	0.000447	0.000764	CcSEcCtD
Zolmitriptan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000444	0.000759	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000441	0.000754	CcSEcCtD
Zolmitriptan—Nausea—Galantamine—Alzheimer's disease	0.000441	0.000754	CcSEcCtD
Zolmitriptan—Constipation—Rivastigmine—Alzheimer's disease	0.000437	0.000747	CcSEcCtD
Zolmitriptan—Pain—Rivastigmine—Alzheimer's disease	0.000437	0.000747	CcSEcCtD
Zolmitriptan—Feeling abnormal—Memantine—Alzheimer's disease	0.00043	0.000736	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000427	0.00073	CcSEcCtD
Zolmitriptan—Hypersensitivity—Donepezil—Alzheimer's disease	0.000424	0.000725	CcSEcCtD
Zolmitriptan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000421	0.00072	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000418	0.000714	CcSEcCtD
Zolmitriptan—Urticaria—Memantine—Alzheimer's disease	0.000415	0.000709	CcSEcCtD
Zolmitriptan—Body temperature increased—Memantine—Alzheimer's disease	0.000413	0.000706	CcSEcCtD
Zolmitriptan—Abdominal pain—Memantine—Alzheimer's disease	0.000413	0.000706	CcSEcCtD
Zolmitriptan—Asthenia—Donepezil—Alzheimer's disease	0.000413	0.000706	CcSEcCtD
Zolmitriptan—Pruritus—Donepezil—Alzheimer's disease	0.000407	0.000696	CcSEcCtD
Zolmitriptan—Urticaria—Rivastigmine—Alzheimer's disease	0.000406	0.000694	CcSEcCtD
Zolmitriptan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000404	0.000691	CcSEcCtD
Zolmitriptan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000404	0.000691	CcSEcCtD
Zolmitriptan—Diarrhoea—Donepezil—Alzheimer's disease	0.000394	0.000673	CcSEcCtD
Zolmitriptan—Hypersensitivity—Memantine—Alzheimer's disease	0.000385	0.000658	CcSEcCtD
Zolmitriptan—Dizziness—Donepezil—Alzheimer's disease	0.00038	0.00065	CcSEcCtD
Zolmitriptan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000376	0.000644	CcSEcCtD
Zolmitriptan—Asthenia—Memantine—Alzheimer's disease	0.000375	0.000641	CcSEcCtD
Zolmitriptan—Pruritus—Memantine—Alzheimer's disease	0.00037	0.000632	CcSEcCtD
Zolmitriptan—Asthenia—Rivastigmine—Alzheimer's disease	0.000367	0.000627	CcSEcCtD
Zolmitriptan—Vomiting—Donepezil—Alzheimer's disease	0.000366	0.000625	CcSEcCtD
Zolmitriptan—Rash—Donepezil—Alzheimer's disease	0.000363	0.00062	CcSEcCtD
Zolmitriptan—Dermatitis—Donepezil—Alzheimer's disease	0.000362	0.00062	CcSEcCtD
Zolmitriptan—Pruritus—Rivastigmine—Alzheimer's disease	0.000361	0.000618	CcSEcCtD
Zolmitriptan—Headache—Donepezil—Alzheimer's disease	0.00036	0.000616	CcSEcCtD
Zolmitriptan—Diarrhoea—Memantine—Alzheimer's disease	0.000357	0.000611	CcSEcCtD
Zolmitriptan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00035	0.000598	CcSEcCtD
Zolmitriptan—Dizziness—Memantine—Alzheimer's disease	0.000345	0.000591	CcSEcCtD
Zolmitriptan—Nausea—Donepezil—Alzheimer's disease	0.000342	0.000584	CcSEcCtD
Zolmitriptan—Dizziness—Rivastigmine—Alzheimer's disease	0.000338	0.000578	CcSEcCtD
Zolmitriptan—Vomiting—Memantine—Alzheimer's disease	0.000332	0.000568	CcSEcCtD
Zolmitriptan—Rash—Memantine—Alzheimer's disease	0.000329	0.000563	CcSEcCtD
Zolmitriptan—Dermatitis—Memantine—Alzheimer's disease	0.000329	0.000563	CcSEcCtD
Zolmitriptan—Headache—Memantine—Alzheimer's disease	0.000327	0.000559	CcSEcCtD
Zolmitriptan—Vomiting—Rivastigmine—Alzheimer's disease	0.000325	0.000555	CcSEcCtD
Zolmitriptan—Rash—Rivastigmine—Alzheimer's disease	0.000322	0.000551	CcSEcCtD
Zolmitriptan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000322	0.00055	CcSEcCtD
Zolmitriptan—Headache—Rivastigmine—Alzheimer's disease	0.00032	0.000547	CcSEcCtD
Zolmitriptan—Nausea—Memantine—Alzheimer's disease	0.00031	0.00053	CcSEcCtD
Zolmitriptan—Nausea—Rivastigmine—Alzheimer's disease	0.000303	0.000519	CcSEcCtD
Zolmitriptan—MAOA—Metabolism—ENO1—Alzheimer's disease	5.86e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—LPL—Alzheimer's disease	5.82e-05	0.000249	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCR5—Alzheimer's disease	5.81e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	5.8e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	5.8e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MEF2C—Alzheimer's disease	5.77e-05	0.000247	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CRH—Alzheimer's disease	5.77e-05	0.000246	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP2D6—Alzheimer's disease	5.75e-05	0.000245	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	5.73e-05	0.000245	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCR5—Alzheimer's disease	5.69e-05	0.000243	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HTR2A—Alzheimer's disease	5.69e-05	0.000243	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PRKCG—Alzheimer's disease	5.66e-05	0.000242	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NPS—Alzheimer's disease	5.58e-05	0.000238	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HTR2A—Alzheimer's disease	5.57e-05	0.000238	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PPP3CA—Alzheimer's disease	5.56e-05	0.000237	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NGF—Alzheimer's disease	5.52e-05	0.000236	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—F2—Alzheimer's disease	5.49e-05	0.000234	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTK2B—Alzheimer's disease	5.47e-05	0.000234	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NPS—Alzheimer's disease	5.47e-05	0.000233	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—BCHE—Alzheimer's disease	5.45e-05	0.000233	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PPP3CA—Alzheimer's disease	5.44e-05	0.000232	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	5.43e-05	0.000232	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—F2—Alzheimer's disease	5.37e-05	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCR5—Alzheimer's disease	5.37e-05	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTK2B—Alzheimer's disease	5.36e-05	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NTRK2—Alzheimer's disease	5.33e-05	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GAB2—Alzheimer's disease	5.33e-05	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SST—Alzheimer's disease	5.33e-05	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CALM1—Alzheimer's disease	5.3e-05	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GSK3A—Alzheimer's disease	5.28e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HTR2A—Alzheimer's disease	5.25e-05	0.000224	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GAB2—Alzheimer's disease	5.21e-05	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NTRK2—Alzheimer's disease	5.21e-05	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SST—Alzheimer's disease	5.21e-05	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CALM1—Alzheimer's disease	5.19e-05	0.000222	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APP—Alzheimer's disease	5.19e-05	0.000222	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLD3—Alzheimer's disease	5.18e-05	0.000221	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.18e-05	0.000221	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GSK3A—Alzheimer's disease	5.17e-05	0.000221	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PLCB1—Alzheimer's disease	5.14e-05	0.000219	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.12e-05	0.000219	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	5.11e-05	0.000218	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APP—Alzheimer's disease	5.08e-05	0.000217	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	5.04e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—F2—Alzheimer's disease	4.98e-05	0.000213	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ABCA1—Alzheimer's disease	4.98e-05	0.000213	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	4.96e-05	0.000212	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	4.95e-05	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CALM1—Alzheimer's disease	4.9e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PLCB1—Alzheimer's disease	4.9e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—LEP—Alzheimer's disease	4.88e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—APOE—Alzheimer's disease	4.88e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—F2—Alzheimer's disease	4.88e-05	0.000208	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.85e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CAV1—Alzheimer's disease	4.84e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PLCB1—Alzheimer's disease	4.8e-05	0.000205	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	4.78e-05	0.000204	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	4.77e-05	0.000204	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	4.67e-05	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ESR1—Alzheimer's disease	4.66e-05	0.000199	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ND1—Alzheimer's disease	4.61e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—F2—Alzheimer's disease	4.6e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	4.57e-05	0.000195	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NGFR—Alzheimer's disease	4.57e-05	0.000195	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	4.55e-05	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CREB1—Alzheimer's disease	4.54e-05	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	4.52e-05	0.000193	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.51e-05	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOTCH1—Alzheimer's disease	4.51e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NGFR—Alzheimer's disease	4.47e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADAM10—Alzheimer's disease	4.46e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CREB1—Alzheimer's disease	4.45e-05	0.00019	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL2—Alzheimer's disease	4.44e-05	0.00019	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	4.39e-05	0.000188	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADAM10—Alzheimer's disease	4.37e-05	0.000187	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL2—Alzheimer's disease	4.35e-05	0.000186	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	4.33e-05	0.000185	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	4.29e-05	0.000183	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HMOX1—Alzheimer's disease	4.27e-05	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	4.24e-05	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GSK3B—Alzheimer's disease	4.23e-05	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—S100B—Alzheimer's disease	4.22e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CREB1—Alzheimer's disease	4.19e-05	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—INS—Alzheimer's disease	4.17e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	4.16e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	4.14e-05	0.000177	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—S100B—Alzheimer's disease	4.13e-05	0.000176	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.13e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL2—Alzheimer's disease	4.1e-05	0.000175	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	4.09e-05	0.000175	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	4.08e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF1—Alzheimer's disease	4.03e-05	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF2—Alzheimer's disease	4.02e-05	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	3.97e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SST—Alzheimer's disease	3.97e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	3.97e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	3.96e-05	0.000169	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	3.94e-05	0.000168	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF2—Alzheimer's disease	3.93e-05	0.000168	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—LPL—Alzheimer's disease	3.91e-05	0.000167	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1R—Alzheimer's disease	3.89e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APP—Alzheimer's disease	3.87e-05	0.000165	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1R—Alzheimer's disease	3.8e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LPL—Alzheimer's disease	3.72e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	3.72e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MEF2C—Alzheimer's disease	3.69e-05	0.000158	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOS3—Alzheimer's disease	3.66e-05	0.000156	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	3.65e-05	0.000156	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LPL—Alzheimer's disease	3.65e-05	0.000156	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PRKCG—Alzheimer's disease	3.62e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MEF2C—Alzheimer's disease	3.61e-05	0.000154	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.56e-05	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRKCG—Alzheimer's disease	3.55e-05	0.000151	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NGF—Alzheimer's disease	3.53e-05	0.000151	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTHFR—Alzheimer's disease	3.52e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NGF—Alzheimer's disease	3.45e-05	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR5—Alzheimer's disease	3.43e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	3.41e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	3.39e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR5—Alzheimer's disease	3.36e-05	0.000144	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HTR2A—Alzheimer's disease	3.36e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	3.33e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	3.31e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HTR2A—Alzheimer's disease	3.29e-05	0.00014	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CALM1—Alzheimer's disease	3.29e-05	0.00014	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOE—Alzheimer's disease	3.28e-05	0.00014	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CAV1—Alzheimer's disease	3.25e-05	0.000139	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.24e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	3.15e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—Alzheimer's disease	3.13e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CALM1—Alzheimer's disease	3.13e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOE—Alzheimer's disease	3.12e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LEP—Alzheimer's disease	3.12e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—Alzheimer's disease	3.11e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CAV1—Alzheimer's disease	3.09e-05	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—Alzheimer's disease	3.09e-05	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CALM1—Alzheimer's disease	3.07e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOE—Alzheimer's disease	3.06e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LEP—Alzheimer's disease	3.06e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CAV1—Alzheimer's disease	3.03e-05	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	3e-05	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ESR1—Alzheimer's disease	2.98e-05	0.000127	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CHAT—Alzheimer's disease	2.97e-05	0.000127	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TPI1—Alzheimer's disease	2.97e-05	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—F2—Alzheimer's disease	2.94e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ESR1—Alzheimer's disease	2.92e-05	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	2.9e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—F2—Alzheimer's disease	2.88e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH1—Alzheimer's disease	2.88e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK8—Alzheimer's disease	2.85e-05	0.000122	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—Alzheimer's disease	2.85e-05	0.000122	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MAOB—Alzheimer's disease	2.85e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—Alzheimer's disease	2.85e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	2.82e-05	0.000121	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—INS—Alzheimer's disease	2.8e-05	0.00012	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	2.78e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	2.75e-05	0.000118	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	2.74e-05	0.000117	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.71e-05	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GSK3B—Alzheimer's disease	2.7e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	2.7e-05	0.000115	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.69e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CREB1—Alzheimer's disease	2.68e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—INS—Alzheimer's disease	2.67e-05	0.000114	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—A2M—Alzheimer's disease	2.65e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GSK3B—Alzheimer's disease	2.65e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—Alzheimer's disease	2.64e-05	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	2.63e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CREB1—Alzheimer's disease	2.63e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL2—Alzheimer's disease	2.62e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—INS—Alzheimer's disease	2.61e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1—Alzheimer's disease	2.58e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL2—Alzheimer's disease	2.57e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	2.56e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1—Alzheimer's disease	2.53e-05	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	2.51e-05	0.000107	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NOS3—Alzheimer's disease	2.45e-05	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—Alzheimer's disease	2.42e-05	0.000103	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.36e-05	0.000101	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOS3—Alzheimer's disease	2.34e-05	9.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	2.34e-05	9.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	2.33e-05	9.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	2.33e-05	9.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	2.31e-05	9.86e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.31e-05	9.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOS3—Alzheimer's disease	2.29e-05	9.78e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.28e-05	9.73e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—Alzheimer's disease	2.25e-05	9.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	2.22e-05	9.5e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—F2—Alzheimer's disease	2.2e-05	9.38e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.16e-05	9.23e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.16e-05	9.23e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.15e-05	9.18e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.12e-05	9.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.02e-05	8.61e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.01e-05	8.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	2e-05	8.56e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	2e-05	8.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—Alzheimer's disease	1.99e-05	8.5e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—INS—Alzheimer's disease	1.99e-05	8.5e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	1.99e-05	8.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	1.97e-05	8.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.96e-05	8.38e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	1.96e-05	8.36e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	1.94e-05	8.31e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	1.93e-05	8.25e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	1.92e-05	8.22e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	1.9e-05	8.1e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.86e-05	7.94e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.84e-05	7.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	1.83e-05	7.8e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—Alzheimer's disease	1.82e-05	7.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	1.82e-05	7.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.79e-05	7.63e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.78e-05	7.61e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.74e-05	7.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.69e-05	7.2e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—Alzheimer's disease	1.68e-05	7.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.65e-05	7.05e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.58e-05	6.76e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.58e-05	6.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.55e-05	6.61e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.51e-05	6.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.5e-05	6.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.48e-05	6.33e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.47e-05	6.29e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.44e-05	6.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.36e-05	5.81e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.36e-05	5.8e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.3e-05	5.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.27e-05	5.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-05	5.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.25e-05	5.33e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.21e-05	5.18e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.21e-05	5.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.2e-05	5.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.17e-05	4.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.15e-05	4.93e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.14e-05	4.87e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—Alzheimer's disease	1.13e-05	4.82e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.08e-05	4.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-05	4.5e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.05e-05	4.5e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—INS—Alzheimer's disease	1.03e-05	4.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	9.5e-06	4.06e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NOS3—Alzheimer's disease	9.05e-06	3.87e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	8.69e-06	3.71e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	8.28e-06	3.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	8.02e-06	3.43e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.16e-06	1.78e-05	CbGpPWpGaD
